Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Filgotinib semen parameters study in adult men with inflammatory arthritis
2018-003933-14Phase 2Completed
- Sponsor
- Galapagos NV
- Start
- Mar 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in rheumatoid arthritis (RA), psoriatic arthritis (PsA), ankylosing spondylitis (AS) and 1 more comparing Filgotinib with Placebo (2 arms). Primary endpoint: Proportion of subjects with a 50% or greater decrease from baseline in sperm concentration at Week 13. Started Mar 2019; status: completed.
02
Drugs
filgotinib
03
Conditions
rheumatoid arthritis (RA)psoriatic arthritis (PsA)ankylosing spondylitis (AS)non-radiographic axial spondyloarthritis (nr-axSpA)
Beyond the preview
Go deeper on 2018-003933-14.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2018-003933-14.